0.3430
+0.0094
+(2.82%)
At close: January 10 at 3:56:31 PM EST
0.3400
-0.00
(-0.87%)
After hours: January 10 at 7:36:59 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-7,681.5740
-15,228.4830
-13,470.2120
-16,952.8640
Investing Cash Flow
-999.9990
-115.5190
-43.8760
--
Financing Cash Flow
6,058.9780
-494.9160
23,140.2160
16,324.4450
End Cash Position
3,144.0490
11,426.7850
27,265.7030
17,639.5750
Interest Paid Supplemental Data
18.8590
9.2900
15.7560
10.0200
Capital Expenditure
--
-127.5190
-43.8760
--
Issuance of Capital Stock
6,669.9780
69.2890
26,676.3920
11,339.3750
Issuance of Debt
--
--
--
132.0880
Repayment of Debt
-611.0000
-564.2050
-524.9800
-329.4210
Repurchase of Capital Stock
--
--
-5,635.6720
--
Free Cash Flow
-8,681.5740
-15,356.0020
-13,514.0880
-16,952.8640
12/31/2020 - 2/25/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VRPX Virpax Pharmaceuticals, Inc.
0.3650
-0.16%
JAGX Jaguar Health, Inc.
1.0000
-8.26%
IGC IGC Pharma, Inc.
0.3450
+4.12%
VTVT vTv Therapeutics Inc.
13.80
-2.06%
SYRS Syros Pharmaceuticals, Inc.
0.2250
+7.14%
TCBP TC Biopharm (Holdings) Plc
0.4005
-1.11%
REVB Revelation Biosciences, Inc.
0.5288
-8.83%
WINT Windtree Therapeutics, Inc.
0.2552
-5.09%
APTO Aptose Biosciences Inc.
0.2200
+3.19%
INAB IN8bio, Inc.
0.3233
+3.42%